The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Open accessPublished version of a preprint
The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Background: The effect of the COVID-19 pandemic on people with Parkinson’s disease (PD) is poorly understood. Objective: To rapidly identify areas of need and improve care in people with PD during the COVID-19 pandemic, we deployed a survey to assess COVID-19 symptoms and the pandemic’s effect among those with and without COVID-19. Methods: People with and without PD participating in the online study Fox Insight (FI) were invited to complete a survey between April 23 and May 23, 2020. Among people reporting COVID-19 diagnoses, we compared symptoms and outcomes in people with and without PD. Among people not reporting COVID-19, we assessed access to healthcare and services and PD symptoms. Results: 7,209/9,762 active FI users responded (approximately 74% response rate), 5,429 people with PD and 1,452 without PD. COVID-19 diagnoses were reported by 51 people with and 26 without PD. Complications were more frequent in people with longer PD duration. People with PD and COVID-19 experienced new or worsening motor (63%) and nonmotor (75%) symptoms. People with PD not diagnosed with COVID-19 reported disrupted medical care (64%), exercise (21%), and social activities (57%), and worsened motor (43%) and non-motor (52%) symptoms. Disruptions were more common for those living alone, with lower income and non-White race. Conclusions: The COVID-19 pandemic is associated with wide-ranging effects on people with PD, and certain groups may be at particular risk. FI provides a rapid, patient-centered means to assess these effects and identify needs that can be used to improve the health of people with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, COVID-19 exacerbates both motor and nonmotor symptoms in PD patients, particularly urinary issues and fatigue.285,286”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [286]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The social isolation imposed by the COVID-19 pandemic greatly affected people with PD (Brown et al., 2020; van der Heide et al., 2020).”
From Online Mindfulness-Based Cognitive Therapy for People with Parkinson’s Disease and Their Caregivers: a Pilot Study (2022) · cites this paper as Brown et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Psychological Impact of Quarantine and How to Reduce It: Rapid Review of the Evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · doi:10.2139/ssrn.3532534 · Cited by 16,394
The psychological impact of quarantine and how to reduce it: Rapid review of the evidence
Brooks, S. K., Webster, R. K., Smith, L. E., Woodland, L., Wessely, S., Greenberg, N., & Rubin, G. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30460-8 · Cited by 16,378 · cited 1×
“In the elderly, social isolation has been associated with more rapid cognitive decline [38], and quarantine in particular can lead to lasting psychological effects [39].”
BackgroundClinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · cited 1×
“Exacerbation of PD symptoms during COVID-19 may in part be due to the inflammatory reaction characteristic of the disease [25].”
BackgroundNeurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674 · cited 1×
“Although COVID-19 has been associated with changes on neuroimaging [20, 21] and SARS-CoV2 RNA has been detected in cerebrospinal fluid [22,”
MethodCDC COVID-19 Response Team, CDC COVID-19 Response Team, Chow, N., Fleming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., Ritchey, M., Roguski, K., et al. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6913e2 · Cited by 1,404
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa330 · Cited by 1,326
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306 · cited 1×
“Men with COVID-19 have been reported to have more severe disease than women [29, 30], while women may be more susceptible [31].”
BackgroundNeuropathological features of Covid-19
Solomon, I. H., Normandin, E., Bhattacharyya, S., Mukerji, S. S., Keller, K., Ali, A. S., Adams, G., Hornick, J. L., Padera, R. F., & Sabeti, P. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2019373 · Cited by 815 · cited 1×
“23], a recent autopsy series of patients that died with COVID-19—all of whom experienced altered mental status—did not find immunohistochemical evidence of encephalitis or viral invasion into brain tissue [24].”
BackgroundSmell dysfunction: a biomarker for COVID‐19
Moein, S. T., Hashemian, S. M., Mansourafshar, B., Khorram‐Tousi, A., Tabarsi, P., & Doty, R. L. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22587 · Cited by 794 · cited 2×
“Hyposmia has been well described in people with COVID-19 [26].”
BackgroundResultAssociation of olfactory dysfunction with risk for future Parkinson's disease
Ross, G. W., Petrovitch, H., Abbott, R. D., Tanner, C. M., Popper, J., Masaki, K., Launer, L., & White, L. R. (2008) · Annals of Neurology · doi:10.1002/ana.21291 · Cited by 742 · cited 1×
“Hyposmia predicts PD-associated clinical and pathological changes [47, 48].”
BackgroundSelf-citation
Research works printed but not linked: 3
- 10.1001/jama-neurol.2020.1452 · doi:10.1001/jama-neurol.2020.1452
- 10.1001/jmaneurol.2020.2581 · doi:10.1001/jmaneurol.2020.2581
- 10.1002/air.22680 · doi:10.1002/air.22680
Cited by
Items 101–175 of 175
Analyzing the effect of the COVID-19 vaccine on Parkinson’s disease symptoms
Sabat, R., Dayton, O. L., Agarwal, A., & Vedam‐Mai, V. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158364 · Cited by 5
“Pre-existing research signifies that the effects of COVID19, especially on elder populations who are unvaccinated, can be deadly (20).”
BackgroundChatterjee, D., Kurup, D., & Smeyne, R. J. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00925-0 · Cited by 5
“Additionally, SARS-CoV-2 infection has also been associated with development of both acute parkinsonism 45 – 49 , and exacerbation of motor and non-symptoms in diagnosed PD patients 50,51 .”
Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Parkinson's Disease
Ba, F., Poonja, S., Torabi, P., Yen, K., Shah, B. D., Noyes, E., Dimapilis, G., Corrick, S., Sankar, T., Rajput, A., et al. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70312 · Cited by 8
“9 Ethnic disparities have also been investigated in PD with respect to quality of life, 10 motor and non-motor symptoms, 11 where White patients often experience improved outcomes in these domains compared to non-White patients.”
Remote Assessment of Parkinson’s Disease Patients Amidst the COVID-19 Lockdown in Mexico
León-García, R., Ortega‐Robles, E., & Arias-Carrión, Ó. (2023) · Brain Sciences · doi:10.3390/brainsci13071114 · Cited by 4
Effect of COVID-19 Related Lockdown on Nonmotor Symptoms of Parkinson's Disease
Banerjee, S., Mukherjee, A., Mohanakumar, K. P., & Biswas, A. (2021) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_65_21 · Cited by 4
“Present study n=55 Turkey[9] n=86 Nine centers of India[10] n=832 Tuscany, Italy[11] n=740 USA[12] n=5429 (people with PD)”
BackgroundInfluentialSpotlight on non-motor symptoms and Covid-19
Rota, S., Boura, I., Wan, Y.-M., Lazcano‐Ocampo, C., Rodríguez‐Violante, M., Antonini, A., & Chaudhuri, К. R. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.001 · Cited by 4
“…that global converging evidence has indicated an increase in anxiety and stress among PwP infected with SARS-CoV-2 compared to healthy controls (Brown et al., 2020; Cilia et al., 2020; Shalash et al., 2020; Suzuki et al., 2021), although anxiety was the only significant predictor of worsening…”
BackgroundInfluentialUnsupervised Walking Activity Assessment Reveals COVID ‐19 Impact on Parkinson's Disease Patients
Vila‐Viçosa, D., Clemente, A., Pona‐Ferreira, F., Leitão, M., Bouça‐Machado, R., Kauppila, L. A., Costa, R. M., Matias, R., & Ferreira, J. J. (2021) · Movement Disorders · doi:10.1002/mds.28514 · Cited by 4
“Figure 1 shows a marked reduction imposed by the COVID-19 confinement in the mobility of PwPD (walking minutes/day), corroborating previous reports about the disrupted activities of surveyed PwPD.(2) In line with previous studies,(4) most PwPD failed to meet the recommended 30 minutes of activity per day (18.”
BackgroundResultInfluentialGoel, A., Narayan, S. K., & Sugumaran, R. (2022) · Acta Neurologica Belgica · doi:10.1007/s13760-022-01891-7 · Cited by 4
Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital
Fearon, C., & Fasano, A. A. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.03.001 · Cited by 4
Racial Differences in Parkinson's Disease Mortality Trends: United States National Mortality Records
Hadidchi, R., Jamil, H., & Gilmour, S. (2025) · Journal of Clinical Neurology · doi:10.3988/jcn.2025.0155 · Cited by 3
Xian, W., Lin, L., Wu, W., Su, F., & Pei, Z. (2024) · Brain and Behavior · doi:10.1002/brb3.3396 · Cited by 4
Ryu, D.-W., Park, J., Lee, M. J., Yoo, D., & Cheon, S. (2024) · Journal of Movement Disorders · doi:10.14802/jmd.23269 · Cited by 3
“During this period of time, a decrease was observed in the number of patients receiving PT interventions and prescriptions for patients with PD. 30-32 Further studies are required to assess the impact of these changes on the health status and health care utilization of patients with PD.…”
The potential association between COVID-19 and Parkinson's disease-like symptoms
Maruki, T., Morioka, S., Kutsuna, S., Kimura, Y., Mochizuki, H., & Ohmagari, N. (2024) · GHM Open · doi:10.35772/ghmo.2024.01003 · Cited by 3
“Furthermore, it has already been reported that COVID-19 exacerbates motor function and neurological deficits in existing patients with PD and causes new symptoms ( 17 ).”
Gotheridge, H., Eccles, F. J. R., Murray, C. D., Henderson, R., & Simpson, J. (2024) · Disability and Rehabilitation · doi:10.1080/09638288.2024.2395460 · Cited by 3
“…to overcome this by creating new questionnaires that investigated perceived worsening in psychological wellbeing as a result of the pandemic [40, 53–60], these were almost entirely excluded from the current review as tests assessing the questionnaires’ reliability and validity were not…”
Impact of Covid-19 on research and training in Parkinson's disease
Wan, Y.-M., van Wamelen, D. J., Lau, Y. H., Rota, S., & Tan, E. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.04.003 · Cited by 3
“On the whole, while 11% felt that the pandemic has made them less likely to participate in research, 6.3% felt that the pandemic has actually made them more likely to participate (Brown et al., 2020).”
BackgroundInfluentialRezayi, S., Katigari, M. R., Shahmoradi, L., & Nilashi, M. (2023) · Parkinson s Disease · doi:10.1155/2023/6272982 · Cited by 2
Hattori, N., Okada, Y., Kawata, Y., Furusawa, Y., Imai, T., Yoshida, H., Ota, M., Arai, M., Shintani, A., & Fernandez, J. L. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s402193 · Cited by 3
“In the US, in an online study of >5000 patients with PD, 43% and 52% of patients not diagnosed with COVID-19 reported worsening of their motor and nonmotor symptoms, respectively.(6) In India, a study of 100 patients with PD indicated that 11% of patients experienced aggravation of their PD symptoms, and 4% had proble…”
Nakanishi, H., Morigaki, R., Fujikawa, J., Ohmae, H., Shinohara, K., Yamamoto, N., Izumi, Y., & Takagi, Y. (2024) · Frontiers in Digital Health · doi:10.3389/fdgth.2024.1486662 · Cited by 5
“Concurrently, numerous studies have underscored the importance of telerehabilitation for patients with PD (16 – 19).”
Tablet-based patient educational interventions in care and management of complex movement disorders
Hellmers, N., Barkan, S., Auerbach, G., Hanineva, A., Popa, P., Sarva, H., & Henchcliffe, C. (2021) · Disability and Rehabilitation Assistive Technology · doi:10.1080/17483107.2021.1900934 · Cited by 3
Wolff, A. W., Haller, B., Demleitner, A. F., Pürner, D., Niederschweiberer, J., Cordts, I., Westenberg, E., & Lingor, P. (2023) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13727 · Cited by 3
Disability as a Determinant of Health:
Ashford, E., Atkins, M., Band, M., Donohue, D. P., Hayman, R. L., Mace, S., & Woodruff, M. (2021) · Delaware Journal of Public Health · doi:10.32481/djph.2021.03.005 · Cited by 2
Tulinský, Ľ., Şengül, İ., Ihnat, P. M., Mitták, M., Toman, D., Pelikán, A., Martínek, L., & Şengül, D. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20221243 · Cited by 2
The Impact of Social Distancing Due to COVID-19 on Activities of Daily Living in Parkinson’s Disease
Sánchez-Herrera-Baeza, P., Rodríguez-Pérez, M. P., Fernández-Gómez, G., Bustamante-Palomo, N., Serrada-Tejeda, S., Obeso‐Benítez, P., Morales-Cabezas, M., Martínez-Piédrola, R. M., & Pérez‐de‐Heredia‐Torres, M. (2023) · Healthcare · doi:10.3390/healthcare11121688 · Cited by 2
“It is important to study how and what impact these prolonged restrictions have had on the functionality and ADLs of patients with PD [11,13,14].”
BackgroundResultXu, Q.-H., Jiang, S., Kang, R., Wang, Y., Zhang, B., & Tian, J. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108200 · Cited by 2
Impact of SARS-CoV-2 Infection on Essential Tremor: A Retrospective Clinical and Kinematic Analysis
Costa, D. D., Grandolfo, A. S., Birreci, D., Angelini, L., Passaretti, M., Cannavacciuolo, A., Martini, A., Riggi, M. D., Paparella, G., Fasano, A. A., et al. (2024) · The Cerebellum · doi:10.1007/s12311-024-01751-5 · Cited by 2
Mukadam, N., Kinger, S. B., Neargarder, S. A., Salazar, R. D., Pluim, C. F., Wall, J., Kaplan, R. I., & Cronin‐Golomb, A. (2025) · Healthcare · doi:10.3390/healthcare13010070 · Cited by 2
“(iv) Prior work [51] showed that COVID-19 infection worsened both motor (e.g., stiffness, tremor, gait) and non-motor (e.g., mood, cognition, fatigue) symptoms in PD.”
Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care
Rukavina, K., McConvey, V., Chaudhuri, К. R., & Miyasaki, J. M. (2022) · International review of neurobiology · doi:10.1016/bs.irn.2022.03.004 · Cited by 2
“…medical care, belonging to a Non-White group was independently associated with difficulties obtaining medications—another concerning finding highlighting the barriers to healthcare access, that might have possibly been exacerbated during the pandemic (Brown et al., 2020; Rukavina et al., 2022).”
BackgroundThe questionnaire survey regarding the impact of COVID-19 pandemic on Parkinson’s disease patients
Tezuka, T., Osada, T., Terayama, Y., Kubota, M., Okusa, S., Shiihashi, G., Kubo, S., Suzuki, N., Nakahara, J., & Seki, M. (2021) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001663 · Cited by 2
Paiva, K. M., Oliveira, R. F., Rocha, G. S., Morais, P. L. A. D. G., de Araújo, D. P., de Oliveira, L. C., Gúzen, F. P., & Cavalcanti, J. R. L. D. P. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.12043 · Cited by 2
Neta, R. D. S. C., Batista, C. D. S., PALMERIM, É. M. M., Dias, H. M. C., Nóbrega, K. C. C., de Oliveira, C. A., & Visco, D. B. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.08.014 · Cited by 2
Yılmaz, N. H., Kılıç, B. B., Zirh, A. T., Aslan, A., & Hanoğlu, L. (2022) · Medical Bulletin of Haseki · doi:10.4274/haseki.galenos.2022.8225 · Cited by 1
“In a previous study, the authors found that living alone during quarantine caused more deterioration of both motor and NMS (33).”
Heath management app use in Parkinson’s disease and quality of life during the COVID-19 pandemic
Tang, Y., Liang, X., Shen, B., Wang, J., Bloem, B. R., Wu, J., & Wang, J. (2023) · Communications Medicine · doi:10.1038/s43856-023-00246-4 · Cited by 3
Huang, P., Tan, Y., Chen, B., Shang, H., Wang, L., Liu, C., Chen, L., Chang, Y., Wang, H., Wang, X., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00399-9 · Cited by 1
“A large online study (Fox Insight) has investigated the effects of the COVID-19 pandemic on PD patients [5].”
BackgroundInfluentialPan, Y., Liang, D., Lu, L., Yu, Z., Wang, B., Luo, W., Wang, P., & Wu, S. Y. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05972-0 · Cited by 3
“…the motor and non-motor symptoms of PD patients have been directly or indirectly affected to some extent, such as bradykinesia, stiffness, rigidity and gait instability have worsened, and anxiety, depression, fatigue, pain, insomnia and cognitive impairment have also been aggravated [12–14].”
BackgroundHumphries, S., Bezuidenhout, L., Häger, C. K., & Conradsson, D. M. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000563 · Cited by 2
Mehta, A., Ng, S. Y., Neo, S., Chia, N. S. Y., Saffari, S. E., Shivashanmugam, T., Choi, X., Heng, D. L., Xu, Z., Tay, K. Y., et al. (2024) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2024.100293 · Cited by 1
Martyr, A., Caulfield, M., Charlwood, C., Gamble, L. D., Prina, M. A., Oyebode, J. R., Hulme, C. T., & Clare, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090146 · Cited by 1
“16 People living alone with neurodegenerative conditions may require more support to maintain independence and to continue to live a safe and fulfilling lifestyle than those living with others.”
Kumar, N. A., & Chaurasia, R. N. (2021) · NMO journal · doi:10.53772/nmo.2021.15106 · Cited by 1
Neurologische Komplikationen bei COVID-19-Infektion
Gülke, E., & Gerloff, C. P. (2021) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1634-2377 · Cited by 1
Care for Parkinson’s Disease Patients in Pakistan: A Call for Help during COVID-19 Pandemic
Zahid, S., Ali, S., & Mohsin, A. (2020) · NeuroRegulation · doi:10.15540/nr.7.4.156
Neurologische Komplikationen bei COVID-19-Infektion
Gülke, E., & Gerloff, C. P. (2022) · Neuroradiologie Scan · doi:10.1055/a-1678-3250
Sheykhangafshe, F. B., Saeedi, M., Sani, A. A., Kiani, A., & Niri, V. S. (2022) · Iranian Journal of Neurosurgery · doi:10.32598/irjns.8.8
“[14] investigated the effects of the COVID-19 epidemic on the lives of patients with PD.”
BackgroundKuppusamy, C., Noorudin, M., Harishkumar, D. P., Mohanan, K. J. P., & Ezhumalai, S. (2022) · PubMed
Anticipated Long-Term Neurobehavioral Outcomes Following COVID-19
Bailey, E. K., Kamper, J. E., & Gius, B. K. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_30
Fontenele, A. V. B., dos Santos, T. A., de Matos, T. M., & Magalhães, A. T. (2022) · Fisioterapia Brasil · doi:10.33233/fb.v23i5.5175
“o isolamento social, que os impossibilitaram de se manterem fisicamente ativos [27-30].”
BackgroundKurt, M., Savaş, D., Şimşek, T. T., & Yiş, U. (2022) · Somatosensory & Motor Research · doi:10.1080/08990220.2022.2157392
“…and paediatric populations with/out neurological conditions show that COVID-19 restrictions cause a decrease in the physical activity levels of people (Brown et al. 2020; Elran-Barak and Mozeikov 2020; Jukic et al. 2020; Pietrobelli et al. 2020; di Stefano et al. 2021;; Stockwell et al. 2021).”
BackgroundComparison of Parkinson’s patients with and without COVID-19 in terms of prognosis
Eren, F., Dikmen, Y., Gur, M. N., Ekmekci, A. H., Sümer, Ş., & Öztürk, Ş. (2023) · Neurology Asia · doi:10.54029/2023dfx
Mecanismos fisiopatológicos asociados al daño neurológico por Covid-19
Gaya, J. A., Corrales, O. P., Rodríguez, I., Medrano, L. L., Sanchez, A. M. V., & Burgos, Y. C. D. P. (2022) · Revista Ciencias Biomédicas · doi:10.32997/rcb-2022-3778 · Cited by 1
Covid-19 : manifestations et complications neurologiques à la phase aiguë de la maladie
de Broucker, T. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2023.02.014
“[27] Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, et al.”
Weber, G. C., Timpka, J., Bergquist, F., Bäckström, D. C., Dizdar, N., Gunnarsson, K., Nyholm, D., Svenningsson, P., & Odin, P. (2023) · Acta Neurologica Scandinavica · doi:10.1155/2023/8025566
“observed that although PD patients who have suffered through COVID-19 reported worse nonmotor and motor function, PD patients not diagnosed with SARS-CoV-2 infection also reported this, be it a lower, yet still alarming, frequency [3].”
BackgroundCanadian Healthcare Access in Parkinson’s Disease and COVID-19: A Cross-Sectional Survey
McKeown, M. D., Crighton, E., & Mestre, T. (2023) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2023.275
“7,8 A scoping review on the psychological and social impacts of the COVID-19 pandemic for PwP identified discontinuation of regular healthcare appointments, decreased physiotherapy appointments, loss of daily activities and socialsupport, and reduction in physical activity as key changes in PD care.”
Complicaciones de la enfermedad de Parkinson relacionadas con la infección por SARS-CoV-2
Castillo, K. E. B., Hermida, D. F. R., & Bermeo, K. M. T. (2023) · Revista Vive · doi:10.33996/revistavive.v6i17.254
Parkinson's disease physical therapy services during COVID‐19: A phenomenological study
Tham, A. Y. Z., Harrison, E. G., & Farlie, M. K. (2023) · Australian Journal on Ageing · doi:10.1111/ajag.13259
“4 Reduced physical activity has been reported as a primary source of distress responsible for the perceived worsening of health.”
BackgroundPsychological Impact of COVID-19 on individuals: Through Active Choices and Passive Adaption
Fang, J., Lau, C. K. M., & Cheng, Y. (2024) · Frontiers research topics · doi:10.3389/978-2-8325-4481-5
Арьев, А. Л., & Лаптева, Е. С. (2024) · Успехи геронтологии · doi:10.34922/ae.2023.36.6.006
Khobkhun, F., Srivanitchapoom, P., Thanakamchokchai, J., & Richards, J. (2024) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2024.03.039
Jain, P., Naithani, U., Prakash, V., & Gabrani, R. (2024) · Research Square · doi:10.21203/rs.3.rs-4138651/v1
Pathogenesis of neuropsychic complications of new coronavirus infection
Klimov, N. A., & Валерьевна, Ш. О. (2023) · Medical academic journal · doi:10.17816/maj624867
The effects of COVID-19 isolations on nonmotor features of Parkinson’s disease
Santangelo, G., & Vitale, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95650-5.00008-2
DeMarco, E. C., Pruthi, S., Cotter, A., Davids, T., Ravi, A., DeVeydt, A., Subramaniam, D. S., Spencer, A. J., Park, S., & Hinyard, L. (2024) · International Journal of Care and Caring · doi:10.1332/23978821y2024d000000055
Kataoka, H., Saeki, K., Tai, Y., Nanaura, H., Kiriyama, T., Sugie, K., & Obayashi, K. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107161
People living alone with neurodegenerative conditions: a scoping review protocolPreprint
Martyr, A., Caulfield, M., Charlwood, C., Gamble, L. D., Prina, M. A., Oyebode, J. R., Hulme, C. T., & Clare, L. (2025) · medRxiv · doi:10.1101/2025.03.12.25323814
Rafizadeh, F., Fakhr, M. S., Esmaeili, E., Amini, Z., Amiri, K., Mardmomen, D., Aqajani, H., & Naeeni, R. H. (2025) · Clinics · doi:10.1016/j.clinsp.2025.100605
Deep Phenotyping Long-COVID Postural Tachycardia SyndromePreprint
Larsen, N. W., Taha, H. B., Seliger, J., Shaik, R., Machnik, J. V., Lansberg, M. G., Muppidi, S., Jaradeh, S. S., Gibbons, C. H., Utz, P. J., et al. (2025) · medRxiv · doi:10.1101/2025.04.28.25326587 · Cited by 1
“40,41 A large cohort study showed that those who had COVID were at 1.5x greater risk of developing Parkinson-like symptoms within 12 months compared to historical controls without COVID.”
Yıldız, D., Pekel, N. B., Yüksel, M., Özdemir, A., Kenan, E. Ç., & Öztürkci, M. F. (2025) · Acta Neurologica Belgica · doi:10.1007/s13760-025-02888-8
“In contrast, more recent data demonstrate that longer disease duration is associated with higher risks of pneumonia, oxygen requirement, and hospitalization in PD patients with COVID-19 [9].”
Şahin, M., Barğı, G., Ünal, Y., & Özdemir, Ö. Ç. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03938-w
“The result of an online study, which is that motor symptoms are more pronounced in Parkinson’s patients with COVID-19 [9], is consistent with the result of our study of a significant decrease in subcostal breathing in Parkinson’s patients with COVID-19.”
InfluentialManaging fatigue in Parkinson's disease: Preparing for a randomized controlled trial
Alizadeh, N. S., Packer, T. L., Sturkenboom, I. H. W. M., Warner, G., & Rigby, H. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251388329
“56 Other studies have also shown that the pandemic negatively impacted essential daily activities, and exacerbated physical symptoms, and mental health problems for people with PD. 57 – 59 People with PD were more susceptible to COVID-19 infection and experienced a worse disease course.”
Silva, A. E. F., Costa, P. T., Mello, L. S., Marques, L., & Marson, F. A. L. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70670 · Cited by 1
“…no significant differences in initial COVID ‐ 19 symptoms; however, patients with Parkinson's disease reported worsening of their motor symptoms and emergence of new motor and non ‐ motor manifestations — mood disturbances, cognitive changes, sleep disruption, and loss of functional autonomy [44].”
Das, A., Vivek, V., & Aich, P. (2025) · Discover Immunity. · doi:10.1007/s44368-025-00016-5
“SARS-COV-2 can be considered as a causative agent in disturbing this axis and its manifestations as altered mood and behavior, memory loss, and cognitive dysfunction [85].”
InfluentialBezuidenhout, L., Joseph, C., Thurston, C., Rhoda, A., English, C., & Conradsson, D. M. (2022) · Figshare · doi:10.6084/m9.figshare.19663691
Huang, P., Tan, Y.-Y., Chen, B., Shang, H.-F., Wang, L.-J., Liu, C.-F., Chen, L., Chang, Y., Wang, H., Wang, X.-L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26677502
Uddin, J., DeVille, N. V., Fudolig, M. A., Cross, C. L., Landers, M. R., & Flatt, J. D. (2026) · Journal of Medicine Surgery and Public Health · doi:10.1016/j.glmedi.2026.100226
Moya‐Galé, G., Fernández, I. F., González, X., Manosalvas, K., & Agin‐Liebes, J. (2026) · American Journal of Speech-Language Pathology · doi:10.1044/2025_ajslp-25-00053 · Cited by 2
Diederich, N. J., & Pauly, C. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03267-0
“The stress-inducing lockdown episodes were most relevant, even in patients without COVID-19 infection (Helmich and Bloem 2020; Brown et al. 2020).”
Racial Differences and Temporal Trends in Parkinson’s and Alzheimer’s Disease-RelatedPreprint
Ahmmad, M. R. (2026) · medRxiv · doi:10.64898/2026.10.22.26366001
Metadata
- Authors
- Brown, E. G., Chahine, L. M., Goldman, S. M., Korell, M., Mann, E., Kinel, D. R., Arnedo, V., Marek, K. L., & Tanner, C. M.
- Affiliations
- University of California, San Francisco (US)
- University of Pittsburgh (US)
- University of Rochester (US)
- Michael J. Fox Foundation (US)
- Institute for Neurodegenerative Disorders (US)
- Corresponding author
- Tanner, Caroline M.
- ORCID
- Venue
- Journal of Parkinson's Disease
- Publisher
- SAGE Publications
- Published
- 2020-10-27
- Volume
- 10
- Issue
- 4
- Pages
- 1365-1377
- ISSN
- 1877-7171 (ISSN-L)
- 1877-718X
- PMC
- PMC7683050
- OpenAlex
- W3086892979
- Cited by
- 177
- References
- 54
- Citations by year
- 2026: 4 · 2025: 18 · 2024: 29 · 2023: 25 · 2022: 49 · 2021: 48 · 2020: 4
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Parkinson s Disease (publishedVersion, cc-by)
- medRxiv (acceptedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Defense
- Michael J. Fox Foundation for Parkinson's Research
- Biogen
- University of Pittsburgh
- Oscar Health
- National Institutes of Health
- Centers for Disease Control and Prevention
- University of California, San Francisco
- National Institute for Occupational Safety and Health
- Agency for Toxic Substances and Disease Registry
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- Parkinson's disease, COVID-19 pandemic, COVID-19 symptoms, motor symptoms, non-motor symptoms, health care access, living alone, income inequality, racial disparities, disease duration
- MeSH terms
- COVID-19, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Health Services Accessibility, Humans, Male, Middle Aged, Parkinson Disease, Pneumonia, Viral, Surveys and Questionnaires, Coronavirus Infections, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.